BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31971349)

  • 1. Sex-specific perturbation of complex lipids in response to medium-chain fatty acids in very long-chain acyl-CoA dehydrogenase deficiency.
    Alatibi KI; Wehbe Z; Spiekerkoetter U; Tucci S
    FEBS J; 2020 Aug; 287(16):3511-3525. PubMed ID: 31971349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?
    Wehbe Z; Alatibi K; Jellusova J; Spiekerkoetter U; Tucci S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1591-1605. PubMed ID: 31394165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual dimorphism of lipid metabolism in very long-chain acyl-CoA dehydrogenase deficient (VLCAD-/-) mice in response to medium-chain triglycerides (MCT).
    Tucci S; Flögel U; Spiekerkoetter U
    Biochim Biophys Acta; 2015 Jul; 1852(7):1442-50. PubMed ID: 25887160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidomic and Proteomic Alterations Induced by Even and Odd Medium-Chain Fatty Acids on Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.
    Alatibi KI; Tholen S; Wehbe Z; Hagenbuchner J; Karall D; Ausserlechner MJ; Schilling O; Grünert SC; Vockley J; Tucci S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
    Tucci S; Behringer S; Spiekerkoetter U
    FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medium-chain triglycerides impair lipid metabolism and induce hepatic steatosis in very long-chain acyl-CoA dehydrogenase (VLCAD)-deficient mice.
    Tucci S; Primassin S; Ter Veld F; Spiekerkoetter U
    Mol Genet Metab; 2010 Sep; 101(1):40-7. PubMed ID: 20580297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
    Tucci S
    J Inherit Metab Dis; 2017 May; 40(3):317-323. PubMed ID: 28247148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
    Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
    Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
    Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
    J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.
    Primassin S; Tucci S; Herebian D; Seibt A; Hoffmann L; ter Veld F; Spiekerkoetter U
    J Inherit Metab Dis; 2010 Jun; 33(3):237-46. PubMed ID: 20446112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting-induced oxidative stress in very long chain acyl-CoA dehydrogenase-deficient mice.
    Tucci S; Primassin S; Spiekerkoetter U
    FEBS J; 2010 Nov; 277(22):4699-708. PubMed ID: 20883455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
    Tucci S; Flögel U; Hermann S; Sturm M; Schäfers M; Spiekerkoetter U
    Biochim Biophys Acta; 2014 May; 1842(5):677-85. PubMed ID: 24530811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
    Cox KB; Hamm DA; Millington DS; Matern D; Vockley J; Rinaldo P; Pinkert CA; Rhead WJ; Lindsey JR; Wood PA
    Hum Mol Genet; 2001 Sep; 10(19):2069-77. PubMed ID: 11590124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy.
    Gobin-Limballe S; Djouadi F; Aubey F; Olpin S; Andresen BS; Yamaguchi S; Mandel H; Fukao T; Ruiter JP; Wanders RJ; McAndrew R; Kim JJ; Bastin J
    Am J Hum Genet; 2007 Dec; 81(6):1133-43. PubMed ID: 17999356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Odd- and even-numbered medium-chained fatty acids protect against glutathione depletion in very long-chain acyl-CoA dehydrogenase deficiency.
    Lund M; Heaton R; Hargreaves IP; Gregersen N; Olsen RKJ
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Feb; 1868(2):159248. PubMed ID: 36356723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
    Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
    J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine model.
    Zhao XJ; Mohsen AW; Mihalik S; Solo K; Aliu E; Shi H; Basu S; Kochersperger C; Van't Land C; Karunanidhi A; Coughlan KA; Siddiqui S; Rice LM; Hillier S; Guadagnin E; Giangrande PH; Martini PGV; Vockley J
    Mol Genet Metab; 2023 Jan; 138(1):106982. PubMed ID: 36580829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term dietary effects on substrate selection and muscle fiber type in very-long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
    Tucci S; Pearson S; Herebian D; Spiekerkoetter U
    Biochim Biophys Acta; 2013 Apr; 1832(4):509-16. PubMed ID: 23313579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis.
    Scalais E; Bottu J; Wanders RJ; Ferdinandusse S; Waterham HR; De Meirleir L
    Am J Med Genet A; 2015 Jan; 167A(1):211-4. PubMed ID: 25338548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
    Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.